Natriuretic peptide-guided management in heart failure.

Area of Science:

• Cardiology
• Biomarkers
• Heart Failure Management

Background:

• Heart failure (HF) is a complex syndrome requiring accurate diagnosis and risk stratification.
• Natriuretic peptides are crucial biomarkers for HF diagnosis and prognosis.
• Objective, reproducible natriuretic peptide testing aids clinical care and trial design.

Purpose of the Study:

• To evaluate the role of natriuretic peptides in heart failure management.
• To assess the efficacy of natriuretic peptide-guided therapy compared to usual care.
• To identify areas for future research in natriuretic peptide-guided HF treatment.

Main Methods:

• Review of clinical trials investigating natriuretic peptide-guided heart failure therapy.
• Analysis of the relationship between natriuretic peptide trajectory and clinical outcomes.
• Exploration of challenges and limitations in current natriuretic peptide-guided strategies.

Main Results:

• Natriuretic peptide-guided therapy demonstrates efficacy and safety compared to usual care in HF.
• The correlation between natriuretic peptide levels and clinical benefit is not uniform across all trials.
• Optimal natriuretic peptide target values and testing intervals require further investigation.

Conclusions:

• Natriuretic peptide-guided therapy is a viable approach for longitudinal biomonitoring and escalating HF therapies.
• Further research is essential to refine target natriuretic peptide levels, therapeutic response magnitude, and treatment duration.
• Multimarker panels may offer a more comprehensive approach, pending validation.